Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Formulary Announcements in new ARO System
-
In the new system, if we are creating an email to announce coverage (1 per province), with the only difference in content being the reimbursement criteria, would this be considered a "series" submission?
-
Moved from PAAB Code by
Jennifer Carroll
-
Hello @gmc , hope you had a great long weekend.
A series submission would be acceptable for this type of APS if it meets the series submission requirements of 60% pick-up.